- Home
- BEEM vs PLUR Comparison
BEEM vs PLUR Comparison
Compare BEEM & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BEEM | PLUR |
|---|---|---|
| Founded | 2006 | 2001 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8M | 34.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BEEM | PLUR |
|---|---|---|
| Price | $1.70 | $3.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $4.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 234.3K | 47.8K |
| Earning Date | 11-14-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,668,000.00 | $1,326,000.00 |
| Revenue This Year | N/A | $97.38 |
| Revenue Next Year | $45.61 | $293.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 121.74 |
| 52 Week Low | $1.33 | $3.02 |
| 52 Week High | $4.04 | $7.13 |
Technical Indicators
Market Signals| Indicator | BEEM | PLUR |
|---|---|---|
| Relative Strength Index (RSI) | 36.86 | 37.62 |
| Support Level | $1.81 | $3.10 |
| Resistance Level | $2.00 | $3.92 |
| Average True Range (ATR) | 0.12 | 0.31 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 13.89 | 12.74 |
Price Performance
Historical ComparisonAbout BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.